Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 1,840,379 | reported | 02 Mar 2026 | tx 22+3,967,415−876,616 |
| Chromocell Therapeutics Corp | 77,640 | reported | 02 Jul 2025 | tx 2+103,118 |
| KIORA PHARMACEUTICALS INC | 50,000 | reported | 01 Feb 2019 | tx 2+100,000 |
| Savara Inc | 45,535 | reported | 20 Jan 2017 | tx 4+227,671 |
| Avalo Therapeutics, Inc. |
| 25,000 |
| reported |
| 07 Aug 2019 |
| tx 12+2,977,154−300,000 |
| Mirna Therapeutics, Inc. | 10,000 | reported | 29 Jun 2016 | tx 3+30,000 |
| MEDIMMUNE INC /DE | 0 | reported | 18 Jun 2007 | tx 4+130,000−130,000 |
| ANTARES PHARMA INC | 0 | reported | 24 May 2022 | tx 13+253,162−253,162 |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 0 | reported | 22 Mar 2022 | tx 18+416,325−416,325 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 28+2,196,792−2,196,729 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 100,890 | 14.21 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 196,403 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 328,424 | 0.00 USD | deriv |
| 20 Feb 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 100,171 | 14.40 USD | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 113,169 | 15.95 USD | |
| 02 Jan 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 165,384 | 0.00 USD | |
| 02 Jul 2025 | GRANT_AWARD | Chromocell Therapeutics Corp | 77,640 | — | deriv |
| 02 Jul 2025 | GRANT_AWARD | Chromocell Therapeutics Corp | 25,478 | — | deriv |
| 03 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 195,593 | 8.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 333,705 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 290,728 | 0.00 USD | |
| 04 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 164,947 | 7.92 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 443,973 | 0.00 USD | deriv |
| 06 Mar 2024 | SALE | Aurinia Pharmaceuticals Inc. | 126,981 | 5.60 USD | |
| 20 Feb 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 661,538 | 0.00 USD | |
| 02 Mar 2023 | SALE | Aurinia Pharmaceuticals Inc. | 32,750 | 8.94 USD | |
| 02 Mar 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 667,407 | — | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 49,425 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 30,220 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 20,000 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 46,729 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 58,246 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 48,542 | — | deriv |
| 22 Mar 2022 | OTHER | BIODELIVERY SCIENCES INTERNATIONAL INC | 105,034 | 0.00 USD | |
| 22 Mar 2022 | OTHER | BIODELIVERY SCIENCES INTERNATIONAL INC | 64,164 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 11 May 2021.